Cargando…
POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15)
BACKGROUND: NUP98 gene rearrangements have been reported in acute myeloid leukemia, giving rise to fusion proteins that seem to function as aberrant transcription factors, and are thought to be associated with poor prognosis. FINDINGS: A patient with treatment-related acute myeloid leukemia presente...
Autores principales: | Lisboa, Susana, Cerveira, Nuno, Bizarro, Susana, Correia, Cecília, Vieira, Joana, Torres, Lurdes, Mariz, José M, Teixeira, Manuel R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567982/ https://www.ncbi.nlm.nih.gov/pubmed/23332017 http://dx.doi.org/10.1186/1476-4598-12-5 |
Ejemplares similares
-
A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia
por: Cerveira, Nuno, et al.
Publicado: (2010) -
NUP98 Rearrangement in Acute Myelomonocytic Leukemia With t(11;19)(p15;p12): The First Case Report Worldwide
por: Lim, Hyeon-Ho, et al.
Publicado: (2017) -
Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia
por: Cerveira, Nuno, et al.
Publicado: (2009) -
Windows 3.11 for dummies /
por: Rathbone, Andy
Publicado: (1995) -
Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report
por: Cerveira, Nuno, et al.
Publicado: (2018)